Day: July 16, 2020

The Supervisory Board of Admiral Markets AS intends to appoint Victor Gherbovet as a new Management Board Member from 27.07.2020. Admiral Markets AS shall as of 27.07.2020 have four Management Board Members: Sergei Bogatenkov, Victor Gherbovet, Dmitri Lauš and Jens Chrzanowski.The changes in the Management Board are due to the long-term strategy of Admiral Markets AS and the desire to increase the company’s presence in new global markets.Additional information:Kaia GilCommunication manager of Admiral Markets ASkaia.gil@admiralmarkets.com+372 53 413 764 

Admiral Markets AS-i nõukogu kavatseb nimetada Victor Gherboveti ühingu juhatuse liikmeks alates 27.07.2020. Admiral Markets AS-i juhatusse kuuluvad alates 27.07.2020 neli liiget: Sergei Bogatenkov, Victor Gherbovet, Dmitri Lauš ja Jens Chrzanowski. Muudatused juhatuses tulenevad Admiral Markets AS-i pikaajalisest strateegiast ja soovist kasvatada ettevõtte kohalolekut uutel turgudel.Victor Gherbovet liitus ettevõttega 2008. aastal ning ta kuulub Admiral Markets Group AS juhatusse alates 2017.aastast.Lisainfo: Kaia GilAdmiral Markets AS-i kommunikatsioonijuhtkaia.gil@admiralmarkets.com+372 53 413 764

TORONTO, July 16, 2020 (GLOBE NEWSWIRE) — Amarillo Gold Corporation (Amarillo or the Company) (TSXV: AGC, OTCQB: AGCBF) has achieved another major milestone on its project development schedule for its flagship Posse Gold Project in Goiás State, Brazil. The Company has received a Water Use Permit for its proposed mine from the country’s National Water Agency. Receiving this permit is a precondition to receiving the License to Install, expected in the third quarter of 2020.“This is the next step on our path to construction,” said Mike Mutchler, Amarillo’s Chief Executive Officer. “We are working with Auramet International on construction financing and are on track to starting detailed engineering and execution planning in the third quarter. We are also targeting procurement for long lead items to start in the fourth quarter of this...

MONTRÉAL, 16 juill. 2020 (GLOBE NEWSWIRE) — ATW Tech Inc. (la « Société ») (TSX-V : ATW) annonce aujourd’hui ses résultats pour son exercice terminé le 31 décembre 2019.La Société a généré des revenus de 5,7m$ en 2019 comparativement à 11,9m$ en 2018, soit une diminution de 6,2m$ ou 52%.  Le coût des ventes a totalisé 5,0m$ en 2019 comparativement à 9,8m$ en 2018, soit une diminution de 4,8m$ ou 49% pour une marge (excluant amortissement) de 0,7m$ en 2019 ou 11,9% comparativement à 2m$ ou 17% en 2018.Le 31 juillet 2019, la Société a conclu la vente d’actifs de sa division VuduMobile pour un prix de 1,35m$ dont 1,15m$ a été payé en espèces et 0,2m$ en compensation de dettes fournisseurs, pour un gain sur disposition de 0,7m$.Le 12 février 2020, la Société a annoncé la conversion, par Groupe Gestion G5 Inc., de son prêt convertible...

MELBOURNE, Australia, July 16, 2020 (GLOBE NEWSWIRE) — Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, today announced that it has entered into definitive agreements with several institutional investors for the purchase and sale in a registered direct offering of 1,025,000 American Depositary Shares (“ADSs”), each representing six hundred (600) of the Company’s ordinary shares, at a purchase price of $5.00 per ADS. The closing of the offering is expected to occur on or about July 20, 2020, subject to the satisfaction of customary closing conditions.H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.The gross proceeds to the Company from this offering are expected to be approximately $5.1 million, before deducting...

CAMBRIDGE, Mass., July 16, 2020 (GLOBE NEWSWIRE) — X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel therapies targeting diseases resulting from dysfunction of the CXCR4 pathway, today announced that it will report its financial results for the second quarter ended June 30, 2020, and provide an update on recent business highlights, on July 30, 2020.The Company will host a conference call and webcast on the same day at 8:30 a.m. ET to discuss these financial results and business highlights. The conference call can be accessed by dialing (866) 721-7655 from the United States or (409) 216-0009 internationally, followed by the conference ID: 6091009. The live webcast can be accessed on the investor relations section of X4 Pharmaceuticals’ website at www.x4pharma.com. Following the completion...

CAMBRIDGE, Mass., July 16, 2020 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, will host its second quarter 2020 financial results and corporate update conference call and live audio webcast on Thursday, July 23rd at 8:30 a.m. EDT.Interested participants may access the conference call by dialing (844) 826-0619 (domestic) or (315) 625-6883 (international) and referring to conference ID number 8894505. To join the live webcast, please visit the presentation page of the investor relations section of the Genocea website at https://ir.genocea.com/events-and-presentations. A webcast replay will be available on the Genocea website beginning approximately two hours after the event and will be archived for 90 days.About Genocea Biosciences, Inc.Genocea’s...

FORT WAYNE, Ind., July 16, 2020 (GLOBE NEWSWIRE) — Vera Bradley, Inc. (NASDAQ: VRA), a leading American bag and luggage company and iconic lifestyle brand, and Warner Bros. Consumer Products, are excited to introduce a Harry Potter™-inspired capsule collection including backpacks, handbags, travel duffels, accessories, cozy favorites, and more.The captivating collection features an exclusive Home to Hogwarts™ pattern with nods to the iconic symbols from the Harry Potter™ film series and Vera Bradley’s signature bright, colorful touch. Select pieces are also available in patterns named and styled after each Hogwarts™ house — so whether you aspire to the bravery of Gryffindor, the ambition of Slytherin, the wisdom of Ravenclaw, or the loyalty of Hufflepuff, there’s something for everyone. In true Vera Bradley fashion, the smart styles...

TAMPA, Fla., July 16, 2020 (GLOBE NEWSWIRE) — HCI Group, Inc. (NYSE:HCI), an InsurTech company with operations in insurance, software development and real estate, will hold a conference call on Thursday, August 6, 2020, at 4:45 p.m. Eastern time to discuss results for the second quarter ended June 30, 2020. Financial results will be issued in a press release after the close of the market on the same day.HCI management will host the presentation, followed by a question and answer period.Interested parties can listen to the live presentation by dialing the listen-only number below or by clicking the webcast link available on the Investor Information section of the company’s website at www.hcigroup.com.Date: Thursday, August 6, 2020Time: 4:45 p.m. Eastern time (1:45 p.m. Pacific time)Listen-only toll-free number: (844) 369-8774Listen-only...

— Study demonstrated that treatment with setmelanotide reduced body weight and hunger in individuals living with Bardet-Biedl syndrome —BOSTON, July 16, 2020 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq:RYTM), a late-stage biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity, announced today that results from its Phase 2 study evaluating setmelanotide for the treatment of obesity and insatiable hunger, known as hyperphagia, in patients living with Bardet-Biedl Syndrome (BBS) were published in the peer-reviewed journal Diabetes, Obesity and Metabolism. As previously reported, data from the study demonstrate that treatment with setmelanotide, the company’s melanocortin-4 receptor (MC4R) agonist, reduced body weight and hunger in individuals...